GlassScriptPhysician profile
William T Bacon
NPI 1730181942
$6,188.23
in general payments reported to CMS, 2019-2025
45 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,821 · 2022: $1,243 · 2023: $1,226 · 2024: $1,417 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,124.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $622.12 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $523.31 | 2022-2025 | Mounjaro, Kisunla, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $516.17 | 2021-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $457.80 | 2021-2025 | Xifaxan, Trulance |
| Daiichi Sankyo INC. | $360.73 | 2021-2024 | Injectafer |
| Novo Nordisk INC | $308.44 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $278.42 | 2021-2024 | Xarelto |
| Abbvie INC. | $264.55 | 2021-2024 | |
| Nestle Healthcare Nutrition INC. | $260.96 | 2021-2023 | |
| Pfizer INC. | $229.53 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $162.65 | 2021-2023 | |
| Abbott Laboratories | $142.34 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Amgen INC. | $138.68 | 2021-2024 | Prolia, Evenity |
| Boston Scientific Corporation | $137.74 | 2025 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $129.37 | 2021-2023 | Eliquis |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $126.30 | 2023-2024 | (5091) Amb Mon & Diag Und |
| Glaxosmithkline, LLC. | $121.15 | 2021-2023 | Shingrix, Arexvy |
| Mylan Specialty L.P. | $120.09 | 2021-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $110.60 | 2021-2024 | Capvaxive, Verquvo, Belsomra |
| Eisai INC. | $100.51 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.21 | 2022-2023 | |
| Amarin Pharma, INC. | $86.62 | 2021 | |
| Aimmune Therapeutics, INC. | $85.66 | 2024-2025 | Zenpep |
| Grifols USA, LLC | $84.16 | 2022-2023 | Prolastin-C Liquid |
| Astellas Pharma US INC | $83.57 | 2022-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $82.28 | 2021-2025 | |
| Cvrx, INC. | $50.48 | 2023 | Barostim Neo System |
| Verona Pharma, INC. | $49.50 | 2025 | Ohtuvayre |
| Exact Sciences Corporation | $47.32 | 2023-2024 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $46.64 | 2022-2024 | Ingrezza |
| Idorsia Pharmaceuticals US INC | $45.72 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $42.57 | 2023-2024 | Rexulti, Abilify Maintena |
| Baxter Healthcare | $30.44 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Irhythm Technologies, INC. | $28.79 | 2024 | Zio Monitor, Zio Xt Patch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.31 | 2021 | |
| Phathom Pharmaceuticals, INC. | $25.97 | 2024 | Voquezna |
| Abiomed | $23.64 | 2024 | Impella |
| Ibsa Pharma INC. | $23.11 | 2021 | |
| Bioventus LLC | $20.29 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $18.70 | 2024 | Uptravi, Opsumit |
| Teva Pharmaceuticals USA, INC. | $16.80 | 2022 | |
| Kerecis Limited | $15.23 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $14.34 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.33 | 2021 | |
| Biodelivery Sciences International, INC. | $13.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.